Table 2.

Activity of Proteasome Inhibitors in Rodent Models of Autoimmune and Inflammatory Diseases

Disease/model	Inhibitor	Reference
lupus nephritis	bortezomib	(Neubert et al., 2008)
lupus	PR-957	(Ichikawa et al., 2011)
myasthenia gravis	bortezomib	(Gomez et al., 2011)
multiple sclerosis	bortezomib	(Fissolo et al., 2008)
streptococcal cell-wall induced polyarthritis	bortezomib	(Palombella et al., 1998)
rheumatoid arthritis	PR-957	(Muchamuel et al., 2009)
irritant sensitivity	epoxomicin, YU-101	(Elofsson et al., 1999)
psoriasis	PS-519	(Elliott et al., 2003)
asthma	PS-519	(Elliott et al., 1999)
colitis	bortezomib	(Schmidt et al., 2010)
	PR-957	(Basler et al., 2010)